HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.

Slides:



Advertisements
Similar presentations
Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Advertisements

HOUSING IS HEALTH CARE MARGARET FLANAGAN, LGSW DISABILITY AND CASE MANAGEMENT COORDINATOR Health Care for the Homeless (HCH)
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Strategies and Interventions for Community-Based Organizations Implementing HIV Prevention Joseph Prejean, Ph. D. Capacity Building Branch Division of.
Accessing Male Circumcision with No or Less Cost in Namibia and Lesotho Tigistu Adamu Ashengo MD, MPH Associate Medical Director Jhpiego.
State of Texas HIV Planning &. Goals for the National HIV/AIDS Strategy 1.Reduce new HIV infections 2.Increase access to care and improve health outcomes.
Out of Sight, Out of Time: Injection Drug Users, Hepatitis C, and HIV Policy Daniel Raymond Hepatitis C Policy Analyst Harm Reduction Coalition
North Carolina Harm Reduction Coalition. North Carolina Harm Reduction Coalition (NCHRC) is North Carolina’s only comprehensive harm reduction program.
Organizing Drug Users for Community & Social Change.
Models of Harm Reduction
Nationals HIV/AIDS Strategy and how the mission of Women Accepting Responsibility, Inc. is helping to meet this goal. By She’kell Hutchinson Program Director,
Spreading and Scaling Prevention and Treatment Approaches: Centers of Excellence Model Janet E. Farmer, PhD School of Health Professions University of.
HIV Prevention & Health Promotion for Asian Women Working at Massage Parlors in San Francisco Health Project for Asian Women (HPAW) Center for AIDS Prevention.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Topic 3 Strategies that help reduce the transmission of HIV Slide 3.1.
HIV Prevention, treatment and care among people who inject drugs Fabienne Hariga, MD, MPH Senior HIV Adviser, UNODC Vienna.
Finding and Using HIV Prevention Research to Develop Programs Jeffrey Bernstein, MS Ellen Goldstein, MA Center for AIDS Prevention Studies University of.
Overview of Syringe Exchange Programs New York City Police Academy November 24, 2004.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
Afghanistan’s Present IDUs-HIV/AIDS Situation and future action plan Dr.Saifur-Rehman NACP Director April,11,2007 Islamic Republic of Afghanistan Ministry.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
African Americans and HIV: CA Office of AIDS Response Michelle Roland, MD Chief, Office of AIDS California Department of Public Health.
Divergent Patterns of Amphetamine Use in the City and Rural Areas in Northwest Poland Sobeyko J (1), Leszczyszyn-Pynka M (2), Parczewski M (2), Burris.
Breaking Down Barriers: Access to HIV Testing and Treatment for San Franciscans Affected by Mental Health and Substance Use Prepared for: HIV Prevention.
Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.
Larry Cuellar Adult Viral Hepatitis Prevention Coordinator Texas Department of State Health Services 2010 STREET OUTREACH WORKERS CONFERENCE June 21, 2010.
Harm Reduction.
Application of Patients’ Rights in Cross-Border Health Care Regional meeting and workshop February 2009 Budapest ŠKUC – Magnus, SLOVENIA Miran Šolinc.
Overview of Harm Reduction and Sterile Syringe Access Anna Benyo Syringe Access Policy Coordinator Harm Reduction Coalition New Jersey Syringe Access Informational.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
Comprehensive HIV Prevention Strategies for Most at Risk Populations (MARPs) Anne Goldzier Thomas, Ph.D. US Department of Defense/PEPFAR Ethiopia National.
Hepatitis C, Drug Use and Stigma Liz Allen. What it is Hepatitis C? Hepatitis C is a blood-borne virus Can cause serious damage to the liver First indentified.
Healthcare Reform The “Affordable Care Act” How Will It Affect Substance Abuse Care?
TI for IDUs Sexual IDUBlood Perinatal Unidentified Routes of HIV Transmission SENTINEL SURVEILLANCE 2006 HIV infection in India.
Injection drug use among men who have sex with men (MSM) Dr Adam Bourne Sigma Research London School of Hygiene & Tropical Medicine
Medical Professionalism and its Relationship to Public Health: Physician Advocacy and State Public Health Policy Thomas Kellogg Program Officer and Advisor.
Resource Needs Model Rachel Sanders October 28 th, 2010.
2008 Minnesota HIV/AIDS Surveillance Report - Key Trends Lorraine Teel- Executive Director.
Positive Living Navajo AIDS Network, Inc. Melvin Harrison, Executive Director Marco Arviso, Arizona Medical Case Manager.
ANDROMEDA TRANSCULTURAL HEALTH RICARDO GALBIS, M.D. Executive Director MAY 20, Decatur Street NW Washington, DC
Paradoxes and Problems in Preventing HIV Infection among Injecting Drug Users and Their Sexual Partners in Eastern Europe and Asia Don C. Des Jarlais,
STATE OF THE STATE SHELLEY LUCAS HIV/STD PREVENTION & CARE BRANCH DEPT OF STATE HEALTH SERVICES AUGUST 3, 2015.
TARGETED CAPACITY EXPANSION PROGRAM: SUBSTANCE ABUSE TREATMENT FOR RACIAL/ ETHNIC MINORITY POPULATIONS AT HIGH RISK FOR HIV/AIDS.
1 Transport against HIV/AIDS Mainstreaming the response in South Asia Jean-Noel Guillossou Focal point HIV and Transport Sustainable Department Transport.
Pennsylvania: The State of HCV 2015
Treatment and scale up access TV, ART OST treatment for people who use drug sin SEA Ekta.
Integration of HIV/AIDS, STD, TB and Viral Hepatitis New York State’s Experience Guthrie S. Birkhead, M.D., M.P.H. Director, AIDS Institute Director, Center.
[IN-Mouraria/GAT LOGO] Harm reduction and HIV/HCV responses for several populations: the challenge of integrating responses Ricardo Fuertes, Adriana Curado,
Darrin Aiken – Program Coordinator Christopher Jackson – Prevention Training Specialist.
Alcohol and AIDS: A New Decade Grantsmanship Workshop XIX International AIDS Conference Rome, Italy Kendall J. Bryant, Ph.D., NIAAA Alcohol and AIDS Research.
Association for Women in Psychology Conference “A Model of Integrated Treatment for Women with Co-Occurring Disorders who are at High Risk for HIV” Presented.
Lessons Learned and Novel Investigation Techniques in Response to a Large Community Outbreak of HIV-1 infection Philip J. Peters MD HIV Testing and Biomedical.
Organizing Drug Users for Public Health Policy Changes 17 th International Conference on the Reduction of Drug Related Harm Jason Farrell, Executive Director.
Services and C Leon Wylie Lead Officer Hepatitis Scotland.
Edo Agustian Indonesian Drug Users Network Meaningful Involvement of PWID in Hep C advocacy in Indonesia.
Non-Medical Staff Knowledge, Beliefs and Practices about HIV and Hepatitis for Injection Drug Users Rowe, KA 1, Tesoriero, JM 1, Heavner, KK 1, Rothman,
#AIDS2016 HOW TO LAUNCH PROGRAMMES FOR PEOPLE WHO USE SUBSTANCES AND ARE AFFECTED BY HIV ACROSS MORE GENERALIZED HIV EPIDEMIC SETTINGS.
Families USA Health Action Conference 2017
Integrating Hepatitis into the World of Community Planning
The Indigenous HIV/AIDS Epidemic: Are We Invisible?
Opioid Crisis A Call to ACTION
Jonathan Mermin, MD, MPH RADM, USPHS
Community Intervention Strategies
Peaceful Spirit Treatment Center
Tacoma Needle Exchange Tier Based Care Coordination
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
HA-REACT Joint Action WP4 Testing and Linkage to care Methods:
Lesson 3: Treatment as Prevention
Human Dignity and Harm Reduction
Presentation transcript:

HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS Program

Prevalence rates for HIV/HCV in Upstate New York According to the New York State Department Of Health, AIDS Institute 2003 epidemiological data, approximately 7,126 persons are living with HIV or AIDS According to NYS DOH approximately 198,000 are chronically infected with Hepatitis C

The Crystal Meth Connection The use of Crystal Methamphetamine is connected to the spread of HIV/HCV in Upstate New York Unsafe sex and sharing of injection equipment (“works”) play a large role in both homosexual and heterosexual communities Non-MSM communities have similar amounts of risk when using Crystal Meth and engaging in similar types of high-risk behaviors

Stigma and Challenges Rural communities struggle with issues of stigma and lack of information Geographical challenges Many people may avoid testing because they fear who may see them or what may happen if they test positive for HIV or Hepatitis C

Stigma and Challenges If someone is diagnosed with HIV or HCV, there are fewer resources in rural communities Lack of resources in the areas of: access to treatment (medical and substance use), case management, secondary prevention, medications, advocacy and qualified medical professionals

Treatment Approaches for Chemically Addicted Traditional treatment approaches are abstinence based Punitive in nature Focus is on Behavior Modification or Cognitive Behavioral Therapy Harm Reduction is just beginning to make inroads into treatment Harm Reduction: syringe exchange, controlled use, reduced use, abstinence one possible outcome

Addiction Treatment and other options for Crystal Meth users Abstinence based treatment has a place but cannot be the only option Harm Reduction must be utilized in its full spectrum The Trans-Theoretical Model of Behavior Change has proven successful Syringe Exchanges can reduce transmission even in rural communities Community Wide prevention efforts

Paying for Medical Services and Treatment Medical and other services are expensive and often challenging for those who lack resources If someone has Medicaid, it does not pay for pain medications needed for someone who is undergoing HIV/HCV treatment Medicaid or Insurance is often very limiting for anyone seeking Chemical Dependency Treatment

HIV/HCV Case Management Although there are services in rural areas for HIV case management, the coverage area of these organizations, like STAP, are very large and staff is limited. Currently, no funding has been made available at the federal/state level to support case management for mono-infected HCV individuals.

Solutions and Interventions Because access to medications is limited for rural communities, clinical trials and Compassionate Care (a program funded by several drug companies like Roche Pharmaceuticals) is the only way for HIV/HCV positive individuals to receive this care

Solutions….. Alternative therapies like massage therapy;acupuncture;chiropractic care and nutritionists can be a very positive experience for people living with HIV/HCV STAP offers programs like: Healing Hands Network, a supplement program, educational programs for clients and providers, and a support group for Co-infected and HCV mono-infected individuals

Solutions… STAP does a tremendous amount of Outreach and sponsors Testing days for both HIV and HCV. The results of these efforts have a community-wide impact. Newsletters, Assessment and Referral services have assisted our clients with access to information and resources

Solutions Operating the only rural Syringe Exchange Program in New York State has enabled us to provide clean sterile syringes, information, referral and support to those who inject drugs, use steroids or inject hormones Crystal Meth is gaining popularity among IDU’s in our area

Solutions Rural Community Based Organizations have excellent networks and relationships with providers in their area. This is crucial to providing services Developing relationships with specific physicians has resulted in access to more up to date information

Funding Issues Funding for HIV case management and prevention programming is not growing. Pharmaceutical companies will sometimes provide grants for conferences, supplement programs and other needs We have a Community Block Grant (CDBG), but it is limited to one city

Funding Issues It is challenging to get funding for rural treatment and case management programs. Funds are often prioritized toward urban areas with higher incidence In NYS we have AIDS Institute to assist with some funding. But we must rely on grants from other sources Funding entities often mandate the terms of service delivery Currently, no federal or state funding for Hepatitis C mono-infection case management or prevention programming exists in our area.

Where do we go from here? Federal Level State Level

Thank You